Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,500
Closed -$39K 952
2022
Q3
$39K Hold
2,500
﹤0.01% 608
2022
Q2
$63K Hold
2,500
﹤0.01% 544
2022
Q1
$90K Buy
2,500
+1,000
+67% +$49.2K ﹤0.01% 509
2021
Q4
$115K Sell
1,500
-27
-2% -$2.38K ﹤0.01% 477
2021
Q3
$147K Hold
1,527
﹤0.01% 432
2021
Q2
$163K Buy
1,527
+1,500
+5,556% +$148K ﹤0.01% 418
2021
Q1
$2K Hold
27
﹤0.01% 1034
2020
Q4
$3K Buy
+27
New +$2.01K ﹤0.01% 969

Other funds holding CRNC

HM Payson & Co's CRNC Position: Q4 2022 in Review

HM Payson & Co sold out of Cerence (CRNC) in Q4 2022, closing a stake of 2,500 shares — an estimated $39K sold.

HM Payson & Co first reported a position in CRNC in Q4 2020 and held it in 8 quarters. The position peaked at $163K in Q2 2021. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.

  • HM Payson & Co reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
  • HM Payson & Co sold 2,500 Cerence shares in Q4 2022, an estimated $39K.
  • HM Payson & Co first reported a position in Cerence in Q4 2020 and held it in 8 quarters.
  • HM Payson & Co's Cerence position peaked at $163K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.

Based on HM Payson & Co's 13F filing for Q4 2022, filed 6 Feb 2023.